header advert
Results 1 - 6 of 6
Results per page:
Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXIX | Pages 18 - 18
1 Jul 2012
Odumenya M Dhillon M Hutchinson CE Spalding T Kolawole R Thompson PJM
Full Access

Purpose of Study

To identify the degree of morphological change achievable following the Bereiter trochleoplasty and to establish whether these results are comparable with functional outcomes.

Methods

Seventeen consecutive patients (19 knees) with patellar instability secondary to trochlear dysplasia underwent trochleoplasty, of which 12 knees (12 patients) were radiologically evaluated pre- and post surgery using axial CT and MRI imaging. Their mean age at time of surgery was 28.1 years (15 to 44). The mean follow-up was 2.2 years (0.5 to 5). The following four radiological outcomes were used: trochlear depth (TD), transverse patellar shift (TPS), lateral patellar inclination angle (LPIA) and sulcus angle (SA). All knees were assessed post-operatively using MRI. The axial CT images were reformatted which allowed for direct comparison with MRI. Each knee was radiologically evaluated twice by a senior musculoskeletal radiology consultant to increase data accuracy and assess for intra-observer reliability using the intraclass correlation coefficient (ICC). Functional outcomes consisted of the KOOS, Lysholm, Kujala and Tegner scores.


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_IX | Pages 85 - 85
1 Mar 2012
Odumenya M Dunn K Spalding T Thompson PJM
Full Access

Purpose of Study

To identify the early functional outcomes, survivorship and complications associated with the Corin Uniglide Unicompartmental Knee Replacement (UKRs) from an independent centre.

Methods and Results

A prospective consecutive case series of sixty Uniglide UKRs was carried out in fifty-one patients between January 2006 and March 2009. The data collected included:

Primary outcome measures:

Pre- and post-operative American Knee Society Score (AKSS), Oxford Knee Scores (OKS), WOMAC

Survivorship

Secondary outcome measures:

X-ray error scores assessing component position

Complications

No cases were lost to follow-up. Mean follow-up time was 19 months (12 to 36months) and mean age was 66 years (39 to 78 years).

Kaplan-Meier Survivorship showed 95% survival at 3 years (CI:6.4).

All functional outcomes showed significant improvement p <0.05. There were two revisions within the first year, which were the main complications, secondary to aseptic tibial loosening and collapse of the posteromedial tibia. The x-ray error score identified the most common error as the femoral flexion/extension angle followed by the anterior/posterior fit.


Orthopaedic Proceedings
Vol. 93-B, Issue SUPP_IV | Pages 410 - 410
1 Nov 2011
Odumenya M Costa ML Krikler SJ Parson N Achten J
Full Access

Purpose of Study: To identify the functional outcome, quality of life and prosthesis survivorship in patients who have undergone the Avon patellofemoral arthroplasty at an independent centre.

Method and Results: Sixty-three patellofemoral arthroplasty (PFA) procedures were undertaken on 44 patients between May 1998 to May 2007. The primary and secondary outcome measures were knee function and quality of life, respectively. These outcomes were determined using the Oxford Knee Score (OKS) and EQ-5D and visual analogue score. Out of the forty-four patients 6 were deceased and 6 were lost to follow-up.

Therefore, thirty-two patients (50 PFAs) were included; nine males and 23 females.

Seventeen patients had bilateral PFA. The mean age of the patients was 65.8 years (SD 9.2). Follow-up averaged at 5.34years (range 2.1–10.2years) (SD2.64). The Oxford Knee Scores in this population showed a bimodal distribution. One group centred around 35 and the other around 60. The median Oxford knee score was 42.5 (IQR 34.25 to 54.25). Two sample t-test analysis of the population, divided as those above and below an OKS of 42, showed that follow-up time and age, did not differ between the groups (p=0.325, p=0.255 respectively). The quality of life outcome scores were significantly lower for bilateral compared to unilateral patients, with median scores of 50 and 72.5 respectively (p=0.03829). The cumulative survival at 5years for those with minimum 5 year follow-up (32 out of 50 PFA) was 100%. Three knees in total were revised. One patient developed bilateral tibiofemoral osteoarthritis, requiring revision to total knee replacement (TKA) at seven and 10 years. Another had persistent anterior knee pain and was converted to a TKA.

Conclusion: The Avon patellofemoral arthroplasty provides good functional outcome. The survivorship rate is promising although longer follow-up is required. Prudent patient selection is needed avoid high rates of revision to TKA.


Orthopaedic Proceedings
Vol. 92-B, Issue SUPP_III | Pages 413 - 413
1 Jul 2010
Odumenya M Costa ML Krikler SJ Parson N Achten J
Full Access

Purpose of Study: To identify the functional outcome, quality of life and prosthesis survivorship in patients who have undergone the Avon patellofemoral arthroplasty at an independent centre.

Method and Results: Sixty-three patellofemoral arthroplasty (PFA) procedures were undertaken on 44 patients between May 1998 to May 2007. The primary and secondary outcome measures were knee function and quality of life, respectively. These outcomes were determined using the Oxford Knee Score (OKS) and EQ-5D and visual analogue score. Out of the forty-four patients 6 were deceased and 6 were lost to follow-up. Therefore, thirty-two patients (50 PFAs) were included; nine males and 23 females. Seventeen patients had bilateral PFA. The mean age of the patients was 65.8 years (SD 9.2). Follow-up averaged at 5.34years (range 2.1–10.2years) (SD2.64). The Oxford Knee Scores in this population showed a bimodal distribution. One group centred around 35 and the other around 60. The median Oxford knee score was 42.5 (IQR 34.25 to 54.25). Two sample t-test analysis of the population, divided as those above and below an OKS of 42, showed that follow-up time and age, did not differ between the groups (p=0.325, p=0.255 respectively). The quality of life outcome scores were significantly lower for bilateral compared to unilateral patients, with median scores of 50 and 72.5 respectively (p=0.03829). The cumulative survival at 5years for those with minimum 5 year follow-up (32 out of 50 PFA) was 100%. Three knees in total were revised. One patient developed bilateral tibiofemoral osteoarthritis, requiring revision to total knee replacement (TKA) at seven and 10 years. Another had persistent anterior knee pain and was converted to a TKA.

Conclusion: The Avon patellofemoral arthroplasty provides good functional outcome. The survivorship rate is promising although longer follow-up is required. Prudent patient selection is needed avoid high rates of revision to TKA.


The Journal of Bone & Joint Surgery British Volume
Vol. 92-B, Issue 1 | Pages 56 - 60
1 Jan 2010
Odumenya M Costa ML Parsons N Achten J Dhillon M Krikler SJ

Between May 1998 and May 2007 we carried out 50 Avon patellofemoral joint replacements in 32 patients with isolated patellofemoral osteoarthritis.

There were no revisions in the first five years, giving a cumulative survival of 100% for those with a minimum follow-up of five years. The mean follow-up was 5.3 years (2.1 to 10.2). The median Oxford knee score was 30.5 (interquartile range 22.25 to 42.25). In patients with bilateral replacements the median Euroqol General health score was 50 which was significantly lower than that of 75 in those with a unilateral replacement (p = 0.047). The main complication was progression of disease, which was identified radiologically in 11 knees (22%). This highlights the need for accurate selection of patients. Our findings suggest that the Avon prosthesis survives well and gives a satisfactory functional outcome in the medium term.


Orthopaedic Proceedings
Vol. 88-B, Issue SUPP_II | Pages 237 - 237
1 May 2006
Haddad F Patel R Al-Hadithy N Odumenya M Grocott M Mythen M
Full Access

Aim: To identify the incidence of post-operative morbidity in elective total hip replacement patients as a cause for prolonged admission using the POMS. To assess the utility of POMS as a measure of short term orthopaedic outcome and a tool to influence decision making for appropriate discharge time.

Background: The currently available methods for assessing overall surgical outcome (as opposed to quality of life or joint specific outcome) are generally unreliable, unvalidated, unresponsive and almost always inconsistent. Mortality is usually infrequent and length of hospital of stay is likely to be affected by non-medical factors and monitoring of complications is subject to variations in both definition and intensity of surveillance.

The POMS is the only published method for prospectively describing complications associated with major surgery. It comprises a 9-point survey and provides a generic measure of short term post-operative outcome. Data is simple and quick to collect and easily learnt. No additional tests are required for data collection.

Method: Patients undergoing elective primary and revision hip arthroplasty were recruited. Research assistants collected POMS data prospectively on postoperative days 1, 3, 5, 8 and 15 (if the patients were still in hospital).

Results: 182 patients were recruited and followed-up. Median length of stay was 11 days (range 2–58). Of the patients remaining in hospital on post-operative days 1, 3, 5, 8 and 15, 0% (n=182), 34% (n=61), 30% (n=51), 29% (n=39) and 63% (n=22), respectively, had no evidence of medical morbidity as defined by the POMS.

Conclusions: The POMS is a generic post-operative screening survey, designed to monitor morbidity in all main organ systems. This study suggests that a significant proportion of orthopaedic patients remain in hospital despite having no evidence of medical morbidity as defined by the POMS. Length of hospital stay is influenced by a number of other factors, further investigation is warranted to identify the factors responsible for their post-operative length of stay. We also hypothesize that POMS may be very useful in areas were managed care / insurance companies dictate the length of hospital stays.